Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Continuous Glucose Monitoring For Prediction and Treatment of Steroid-Induced Hyperglycemia

NCT04210128 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT04210128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04210128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Continuous Glucose Monitoring For Prediction and Treatment of Steroid-Induced Hyperglycemia
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Observational
Overall status
Completed
Start date
December 20, 2019
Completion date
October 31, 2023
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, diabetes, pancreatic cancer, pre diabetes